Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Assets Average: 2014-2025

Historic Assets Average for Ocular Therapeutix (OCUL) over the last 11 years, with Sep 2025 value amounting to $431.1 million.

  • Ocular Therapeutix's Assets Average fell 14.42% to $431.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $431.1 million, marking a year-over-year decrease of 14.42%. This contributed to the annual value of $355.0 million for FY2024, which is 76.90% up from last year.
  • As of Q3 2025, Ocular Therapeutix's Assets Average stood at $431.1 million, which was up 0.58% from $428.6 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Assets Average ranged from a high of $528.0 million in Q2 2024 and a low of $125.6 million during Q2 2023.
  • Over the past 3 years, Ocular Therapeutix's median Assets Average value was $428.6 million (recorded in 2025), while the average stood at $346.1 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Assets Average plummeted by 30.38% in 2023, and later skyrocketed by 320.51% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Assets Average (Quarterly) stood at $211.3 million in 2021, then dropped by 27.15% to $153.9 million in 2022, then skyrocketed by 34.62% to $207.2 million in 2023, then spiked by 128.81% to $474.2 million in 2024, then fell by 14.42% to $431.1 million in 2025.
  • Its Assets Average was $431.1 million in Q3 2025, compared to $428.6 million in Q2 2025 and $431.9 million in Q1 2025.